Drugs Home > Ibritumomab

When and How to Receive Ibritumomab

Some general considerations to keep in mind during treatment with ibritumomab include the following:
 
  • This medication comes as a liquid that is given as an injection into a vein (an intravenous, or IV, injection) over a 10-minute period.
 
  • Ibritumomab is part of a treatment regimen that includes rituximab. It is normally given as a single dose within four hours after receiving a second dose of rituximab.
 
  • The injection will be given by a healthcare provider in a healthcare setting, such as a hospital or clinic.
 
 
  • For the medication to work properly, it must be used as prescribed. It is important to keep your appointment to receive your ibritumomab dose.
 

Storage Information

Your healthcare provider will store ibritumomab. It should be stored under refrigeration, not frozen. The medication must be used within eight hours after preparation of the dose.
 

Is There a Generic Version?

This medication is not available in generic form (see Generic Zevalin).
 

Who Makes Ibritumomab?

Ibritumomab is made by Spectrum Pharmaceuticals, Inc.
 

Available Strengths

Ibritumomab is available in one strength: Ibritumomab 3.2 mg per 2 mL. It must be linked with a radioactive substance known as Yttrium-90 before use.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.